Nanosonics Aktie
2,04EUR | 0,05EUR | 2,51% |
WKN DE: A0MQVE / ISIN: AU000000NAN9
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 311 | 339 | 425 | 482 | 466 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,32 | 0,30 | 0,28 | 0,35 | 0,37 |
Bilanz (in Mio. AUD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 124 | 142 | 151 | 181 | 198 |
Summe Anlagevermögen | 24 | 22 | 43 | 45 | 44 |
Summe Aktiva | 148 | 165 | 194 | 226 | 242 |
Bilanz (in Mio. AUD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 24 | 29 | 55 | 62 | 60 |
Summe Eigenkapital | 124 | 136 | 139 | 164 | 182 |
Summe Passiva | 148 | 165 | 194 | 226 | 242 |
Adresse
Macquarie Park, 2113 Sydney | |
Telefon | +61 (2) 8063-1600 |
Internet | http://www.nanosonics.com.au |
Management
David N. Morris
Chief Strategy Officer |
Gareth Daly
Manager-Key Accounts |
Gerard Dalbosco
Independent Non-Executive Director |
Ines Klatt
Head-Business Development & Sales Lead |
Jason Burriss
Chief Financial Officer |
Jodi Sampson
Chief People & Culture Officer |
Jonathan Burdach
Chief Medical Affairs & Scientific Officer |
Larry R. Marshall
Independent Non-Executive Director |
Lisa Margaret McIntyre
Independent Non-Executive Director |
Marie McDonald
Independent Non-Executive Director |
Matthew Carbines
Secretary & General Counsel |
Matthew Lipscombe
Chief Marketing Officer |
Michael Kavanagh
President, CEO & Executive Director |
Rod Lopez
Chief Operating Officer |
Steven A. Sargent
Chairman |
Sunny Pillai
Chief Information Officer |
Tracey Leigh Batten
Independent Non-Executive Director |